Facebook
Twitter
Telegram
Report an ErrorZosano Pharma Corporation Financial Statements 2011-2024 | ZSAN
Annual Financial Statements Zosano Pharma Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
52.7 M | 35.8 M | 24.9 M | 20 M | 11.6 M | 16.1 M | 26 M | 129 M | - | - | - |
Shares |
112 M | 67.9 M | 16.4 M | 9.45 M | 1.73 M | 689 K | 571 K | 581 K | - | - | - |
Historical Prices |
0.47 | 0.527 | 1.52 | 2.12 | 10.4 | 15.6 | 45.6 | - | - | - | - |
Net Income |
-29.9 M | -33.4 M | -37.6 M | -35.4 M | -29.1 M | -29.8 M | -28.4 M | -14.2 M | -5.61 M | 1.82 M | - |
Revenue |
785 K | 224 | - | - | - | - | 313 K | 2.86 M | 4.25 M | 11.6 M | - |
Cost of Revenue |
796 K | 171 K | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 53 | - | - | - | - | 313 K | 2.76 M | 4.25 M | 11.6 M | - |
Operating Income |
-31.5 M | -32.8 M | -37.2 M | -35.4 M | -28.4 M | -28.6 M | -26.4 M | -12.6 M | - | - | - |
Interest Expense |
189 K | 719 K | 523 K | 379 K | 817 K | -7 K | -97 K | -93 K | - | - | - |
EBITDA |
-29.8 M | -31.3 M | -36.5 M | -34.6 M | -25.8 M | -26.1 M | -23.9 M | -9.57 M | -7.54 M | 4.22 M | - |
Operating Expenses |
- | 33 K | 37.2 M | 34.9 M | 28.4 M | 28.6 M | 26.7 M | 15.4 M | 12.2 M | 8.48 M | - |
General and Administrative Expenses |
10.5 M | 11.2 M | 11.8 M | 9.36 M | 8.18 M | 8.18 M | 6.32 M | 4.42 M | 4.58 M | 3.08 M | - |
All numbers in USD currency
Quarterly Income Statement Zosano Pharma Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | 4.25 M | 120 M | 116 M | 109 M | 2.98 M | 102 M | 77.9 M | 54.9 M | 54.4 M | 23.5 M | 17.8 M | 16.9 M | 12 M | 12 M | 12 M | 11.8 M | 1.97 M | 1.97 M | 39.2 M | 39.2 M | 1.02 M | 841 K | 14.3 M | 12 M | 12 M | 12 M | 12 M | 11.9 M | 9.79 M | 5.16 M | 5.14 M | 5.12 M | 5.11 M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | -33.4 M | - | -8.67 M | -6.14 M | -8.14 M | - | -8.69 M | -7.9 M | -8.69 M | - | -9.86 M | -9.36 M | -9.43 M | - | -8.17 M | -8.84 M | -8.21 M | - | -7.87 M | -6.75 M | -7 M | - | -7.45 M | -6.52 M | -8.12 M | - | -8.62 M | -7.58 M | -4.58 M | - | -3.68 M | -3.91 M | -2.37 M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | 132 K | - | 252 K | 188 K | 258 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 95 K | 218 K | - | 374 K | 506 K | 1.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | 86 K | - | 340 K | 202 K | 162 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | -33.3 M | - | -8.6 M | -7.97 M | -8.05 M | - | -8.53 M | -7.7 M | -8.6 M | - | -9.56 M | -9.41 M | -9.49 M | - | -8.25 M | -8.8 M | -8.07 M | - | -7.72 M | -6.55 M | -6.75 M | - | -7.13 M | -6.25 M | -7.8 M | - | -8.35 M | -6.69 M | -4.15 M | - | -3.11 M | -3.38 M | -2.57 M | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 73 K | - | 17 K | 22 K | 97 K | - | 165 K | 190 K | 206 K | - | 281 K | 35 K | 41 K | - | 79 K | 112 K | 156 K | - | - | 12 K | -2 K | - | - | 50 K | -1 K | - | 41 K | -4 K | 12 K | - | 3 K | -146 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | -33.1 M | - | -8.2 M | -7.57 M | -7.61 M | - | -8.03 M | -7.4 M | -8.42 M | - | -9.36 M | -9.21 M | -9.32 M | - | -8.05 M | -8.6 M | -7.87 M | - | -7.12 M | -5.95 M | -6.12 M | - | -6.53 M | -5 M | -7.18 M | - | -7.75 M | -6.09 M | -3.52 M | - | -2.31 M | -2.58 M | -1.81 M | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | 8.53 M | 7.7 M | 8.6 M | - | 9.56 M | 9.41 M | 9.49 M | - | 8.25 M | 8.8 M | 8.07 M | - | 7.72 M | 6.55 M | 6.75 M | - | 7.13 M | 6.25 M | 7.8 M | - | 8.35 M | 6.78 M | 4.37 M | - | 3.48 M | 3.89 M | 4.17 M | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | 2.94 M | - | 2.52 M | 2.96 M | 2.81 M | - | 2.7 M | 2.77 M | 3.08 M | - | 3.07 M | 2.77 M | 2.87 M | - | 2.35 M | 2.27 M | 2.26 M | - | 2.04 M | 2.19 M | 2.12 M | - | 2.01 M | 1.95 M | 2.18 M | - | 1.72 M | 1.78 M | 1.3 M | - | 894 K | 1.13 M | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency